Adverum Biotechnologies (ADVM) News Today → The “Next Bitcoin”? 10 CENT Crypto Set to Explode (From True Market Insiders) (Ad) Free ADVM Stock Alerts $9.53 +0.34 (+3.70%) (As of 04/29/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMizuho Cuts Adverum Biotechnologies (NASDAQ:ADVM) Price Target to $22.00marketbeat.com - April 29 at 8:07 AMAdverum Biotechnologies, Inc. (NASDAQ:ADVM) Sees Large Increase in Short Interestamericanbankingnews.com - April 28 at 4:16 AMAdverum Biotechnologies to Present LUNA 26-week Phase 2 Interim Analysis at the ASRS Annual Scientific Meetingglobenewswire.com - April 25 at 4:05 PMAdverum Biotechnologies (NASDAQ:ADVM) Shares Pass Below 200 Day Moving Average of $12.09americanbankingnews.com - April 20 at 3:36 AMAdverum Biotechnologies Incmoney.usnews.com - April 18 at 9:36 AMAnalysts Are Neutral on These Healthcare Stocks: SAGE Therapeutics (SAGE), Adverum Biotechnologies (ADVM)markets.businessinsider.com - March 28 at 11:09 AMAdverum Biotechnologies, Inc. (NASDAQ:ADVM) Sees Large Decline in Short Interestmarketbeat.com - March 27 at 10:33 AMChardan Capital Comments on Adverum Biotechnologies, Inc.'s FY2024 Earnings (NASDAQ:ADVM)marketbeat.com - March 22 at 8:35 AMPositive Outlook for Adverum Biotechnologies with Upcoming Ixo-vec Milestones and Strong Financial Positionmarkets.businessinsider.com - March 21 at 7:08 AMmarketbeat.com - March 21 at 6:06 AMAdverum Biotechnologies Reports Encouraging Clinical Progress Amidst Financial Adjustmentsfinance.yahoo.com - March 20 at 9:23 AMIs Adverum Biotechnologies (ADVM) Stock Outpacing Its Medical Peers This Year?finance.yahoo.com - March 19 at 10:59 AMChardan Capital Reiterates Buy Rating for Adverum Biotechnologies (NASDAQ:ADVM)marketbeat.com - March 19 at 9:09 AMAdverum Biotechnologies (NASDAQ:ADVM) PT Lowered to $2.00 at Royal Bank of Canadamarketbeat.com - March 19 at 8:46 AMAdverum Biotechnologies (ADVM) Receives a Buy from TD Cowenmarkets.businessinsider.com - March 19 at 12:17 AMADVM Stock Earnings: Adverum Biotechnologies Beats EPS for Q4 2023investorplace.com - March 18 at 11:01 PMAdverum Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Pipeline Highlights and Corporate Updatesglobenewswire.com - March 18 at 4:05 PMADVM Adverum Biotechnologies, Inc.seekingalpha.com - March 17 at 6:12 PMFmr LLC Sells 1,069,367 Shares of Adverum Biotechnologies, Inc. (NASDAQ:ADVM)marketbeat.com - March 8 at 4:24 AMADVM Apr 2024 5.000 callfinance.yahoo.com - March 6 at 5:59 PMTurn Pocket Change into Profit: 3 Penny Stocks Ready to Popinvestorplace.com - March 6 at 3:07 PMAdverum Biotechnologies to Participate in the TD Cowen 44th Annual Health Care Conferenceglobenewswire.com - February 28 at 4:05 PMStocks on the Launchpad: The Next 3 Market Sensationsinvestorplace.com - February 27 at 6:10 AMAdverum Biotechnologies (ADVM) Price Target Increased by 10.53% to 4.28msn.com - February 25 at 8:01 AMAdverum Biotechnologies Stock (NASDAQ:ADVM), Short Interest Reportbenzinga.com - February 22 at 10:36 AMUnleash Massive Returns With These 3 Top Penny Stocksinvestorplace.com - February 22 at 6:15 AMADVM Feb 2024 4.000 callfinance.yahoo.com - February 15 at 3:20 PMADVM Sep 2024 2.500 putfinance.yahoo.com - February 13 at 10:37 AMAdverum Biotechnologies, Inc. (NASDAQ:ADVM) Sees Significant Decrease in Short Interestmarketbeat.com - February 13 at 5:02 AMAdverum Biotechnologies to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conferencefinance.yahoo.com - February 12 at 10:23 AMAdverum Biotechnologies Inc (ADVM)uk.investing.com - February 9 at 7:41 PMJames Paul Scopa Buys 100,000 Shares of Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Stockmarketbeat.com - February 9 at 7:06 PMWhy Is Blindness Focused-Adverum Biotechnologies Stock Trading Lower Today?msn.com - February 8 at 8:39 PMAdverum Biotechnologies Announces Positive Preliminary Efficacy and Safety Data from LUNA Phase 2 Trial of Ixo-vec in Patients with Wet AMDfinance.yahoo.com - February 8 at 10:35 AMmarketbeat.com - February 8 at 9:37 AMAdverum Biotechnologies Awaits Court Decision on Settlementmsn.com - February 7 at 8:42 AMAdverum Biotechnologies (NASDAQ:ADVM) Given New $4.00 Price Target at Mizuhomarketbeat.com - February 6 at 2:41 PMAdverum Biotechnologies Secures $127.8M in Private Placementmsn.com - February 6 at 12:39 PMAdverum Biotechnologies Executes Private Equity Placementmsn.com - February 6 at 12:39 PMAdverum Biotechnologies, Cano Health among healthcare moversmsn.com - February 5 at 4:37 PMAdverum Biotechnologies Shares Soar on Private Placement Pricingmarketwatch.com - February 5 at 11:37 AMWhy Adverum Biotechnologies Stock Is Trading Higherbenzinga.com - February 5 at 11:37 AMAdverum Biotechnologies Announces $127.5 Million Private Placement Financingfinance.yahoo.com - February 5 at 11:37 AMAdverum Biotechnologies will Host Webcast to Review LUNA Phase 2 Preliminary Efficacy and Safety Results on February 8, 2024finance.yahoo.com - February 1 at 8:30 PMAdverum Biotechnologies Appoints Romuald Corbau, Ph.D. as Chief Scientific Officerfinance.yahoo.com - January 29 at 10:35 AMAdverum Biotechnologies Inc ADVMmorningstar.com - January 12 at 5:51 PMHere's Why You Should Invest in Adverum (ADVM) Stock Nowfinance.yahoo.com - January 4 at 2:12 PM4DMT and Arbor Biotechnologies Establish Partnership to Co-Develop and Co-Commercialize Next-Generation Genetic Medicines for CNS Diseasesmarkets.businessinsider.com - January 3 at 9:27 AMAdverum Biotechnologies to Present LUNA Preliminary Efficacy and Safety Data at the 47th Annual Meeting of the Macula Societyfinance.yahoo.com - December 7 at 7:57 PMPromising Developments in Adverum Biotechnologies’ Gene Therapy Candidate, Ixo-Vec, Drive Graig Suvannavejh’s Bullish Ratingmarkets.businessinsider.com - November 21 at 8:15 AM Get Adverum Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for ADVM and its competitors with MarketBeat's FREE daily newsletter. Email Address The “Next Bitcoin”? 10 CENT Crypto Set to Explode (Ad)The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon… Click For My #1 FREE Crypto for 2024 ADVM Media Mentions By Week ADVM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ADVM News Sentiment▼0.070.34▲Average Medical News Sentiment ADVM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ADVM Articles This Week▼51▲ADVM Articles Average Week Get Adverum Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for ADVM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: STRO News ELEV News CMPX News CHRS News PSTX News XFOR News FENC News IPSC News BDTX News OPT News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ADVM) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingCharles Payne’s Gift to Stock InvestorsUnstoppable ProsperityHe Is Giving Away BitcoinCrypto Swap ProfitsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmith4 coins to be the “Next Bitcoin”True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adverum Biotechnologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
